Scenarios that move NMRA

Neumora Therapeutics, Inc. - Common Stock

Scenarios that move NMRA: 2 analyses, 1 positive, 1 negative.

1. 2026-09-18 · Xenon files epilepsy NDA as depression study setback weighs — ▲ · impact +18 · confidence low · horizon weeks
2. 2026-09-15 · Definium reports second Phase III success in anxiety program — ▼ · impact -30 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing